Niioka T - Search Results

1

A multicenter clinical study evaluating the confirmed complete molecular response rate in imatinib-treated patients with chronic phase chronic myeloid leukemia by using the international scale of real-time quantitative polymerase chain reaction.

Shinohara Y, Takahashi N, Nishiwaki K, Hino M, Kashimura M, Wakita H, Hatano Y, Hirasawa A, Nakagawa Y, Itoh K, Masuoka H, Aotsuka N, Matsuura Y, Takahara S, Sano K, Kuroki J, Hata T, Nakamae H, Mugitani A, Nakane T, Miyazaki Y, Niioka T, Miura M, Sawada K. Shinohara Y, et al. Among authors: niioka t. Haematologica. 2013 Sep;98(9):1407-13. doi: 10.3324/haematol.2013.085167. Epub 2013 May 28. Haematologica. 2013. PMID: 23716542 Free PMC article. Clinical Trial.

2

Effect of pregnane X receptor and cytochrome P450 oxidoreductase gene polymorphisms on trough concentrations of rivaroxaban and edoxaban in patients with nonvalvular atrial fibrillation.

Nakagawa J, Kinjo T, Aiuchi N, Ueno K, Tomita H, Niioka T. Nakagawa J, et al. Among authors: niioka t. Eur J Clin Pharmacol. 2023 May;79(5):703-705. doi: 10.1007/s00228-023-03483-7. Epub 2023 Mar 23. Eur J Clin Pharmacol. 2023. PMID: 36951964 No abstract available.

3

Limited sampling strategy for simultaneous estimation of the area under the concentration-time curve of tacrolimus and mycophenolic acid in adult renal transplant recipients.

Miura M, Satoh S, Niioka T, Kagaya H, Saito M, Hayakari M, Habuchi T, Suzuki T. Miura M, et al. Among authors: niioka t. Ther Drug Monit. 2008 Feb;30(1):52-9. doi: 10.1097/FTD.0b013e31815f5416. Ther Drug Monit. 2008. PMID: 18223463 Clinical Trial.

4

Early phase limited sampling strategy characterizing tacrolimus and mycophenolic acid pharmacokinetics adapted to the maintenance phase of renal transplant patients.

Miura M, Satoh S, Niioka T, Kagaya H, Saito M, Hayakari M, Habuchi T, Suzuki T. Miura M, et al. Among authors: niioka t. Ther Drug Monit. 2009 Aug;31(4):467-74. doi: 10.1097/FTD.0b013e3181ae44b9. Ther Drug Monit. 2009. PMID: 19571775

5

Correlation between R/S enantiomer ratio of lansoprazole and CYP2C19 activity after single oral and enteral administration.

Miura M, Motoyama S, Hinai Y, Niioka T, Hayakari M, Ogawa J, Suzuki T. Miura M, et al. Among authors: niioka t. Chirality. 2010 Jul;22(7):635-40. doi: 10.1002/chir.20810. Chirality. 2010. PMID: 20014035

6

Influence of CYP2C19 and ABCB1 polymorphisms on plasma concentrations of lansoprazole enantiomers after enteral administration.

Miura M, Motoyama S, Hinai Y, Niioka T, Endo M, Hayakari M, Ogawa J. Miura M, et al. Among authors: niioka t. Xenobiotica. 2010 Sep;40(9):630-6. doi: 10.3109/00498254.2010.494201. Xenobiotica. 2010. PMID: 20528170

7

Pharmacogenetic determinants for interindividual difference of tacrolimus pharmacokinetics 1 year after renal transplantation.

Miura M, Niioka T, Kagaya H, Saito M, Hayakari M, Habuchi T, Satoh S. Miura M, et al. Among authors: niioka t. J Clin Pharm Ther. 2011 Apr;36(2):208-16. doi: 10.1111/j.1365-2710.2010.01163.x. J Clin Pharm Ther. 2011. PMID: 21366650

8

Monitoring of mycophenolic acid predose concentrations in the maintenance phase more than one year after renal transplantation.

Miura M, Niioka T, Kato S, Kagaya H, Saito M, Habuchi T, Satoh S. Miura M, et al. Among authors: niioka t. Ther Drug Monit. 2011 Jun;33(3):295-302. doi: 10.1097/FTD.0b013e3182197e38. Ther Drug Monit. 2011. PMID: 21572388

9

Influence of NAT2 polymorphisms on sulfamethoxazole pharmacokinetics in renal transplant recipients.

Kagaya H, Miura M, Niioka T, Saito M, Numakura K, Habuchi T, Satoh S. Kagaya H, et al. Among authors: niioka t. Antimicrob Agents Chemother. 2012 Feb;56(2):825-9. doi: 10.1128/AAC.05037-11. Epub 2011 Nov 21. Antimicrob Agents Chemother. 2012. PMID: 22106207 Free PMC article.

10

Influence of H2-receptor antagonists and proton pump inhibitors on dasatinib pharmacokinetics in Japanese leukemia patients.

Takahashi N, Miura M, Niioka T, Sawada K. Takahashi N, et al. Among authors: niioka t. Cancer Chemother Pharmacol. 2012 Apr;69(4):999-1004. doi: 10.1007/s00280-011-1797-3. Epub 2011 Dec 7. Cancer Chemother Pharmacol. 2012. PMID: 22147077

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

107 results

Search Page

Filters